Veterinary Stents Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

The Global Veterinary Stents Market was valued at USD 47.5 million in 2025 and is estimated to grow at a CAGR of 7% to reach USD 92 million by 2035.

Growth in the veterinary stents market is strongly influenced by the increasing focus on improving animal health and advancing treatment standards within veterinary medicine. As pet ownership continues to rise globally, veterinarians and pet owners are placing greater emphasis on effective medical interventions that enhance the quality of life for companion animals. Veterinary stents are increasingly recognized as an important treatment option for animals experiencing structural narrowing or blockages in vital body passages. At the same time, rapid technological advancements have significantly improved the performance and reliability of these devices. The development of minimally invasive veterinary procedures, along with improved stent designs and advanced biomaterials, has enhanced the success rate of implantation procedures. In addition, improvements in imaging and placement technologies are enabling veterinarians to deliver more precise and efficient treatments. These advancements are contributing to better clinical outcomes, faster recovery for animals, and reduced complication rates. As a result, veterinary stents are gaining wider acceptance among veterinary professionals while also receiving greater trust from pet owners seeking advanced treatment options.

Veterinary stents function as specialized implants designed to treat animals experiencing blockages or narrowing within certain internal pathways caused by disease, injury, or developmental abnormalities. These cylindrical devices are typically manufactured using durable metal alloys or polymer-based materials and are inserted into tubular anatomical structures to maintain proper passage and restore normal physiological function. By providing structural support within affected areas, veterinary stents help improve airflow, circulation, or fluid movement, depending on the location of placement.

The airway stents segment generated USD 18.7 million in 2025. Segment growth is primarily associated with the rising incidence of airway-related disorders among companion animals that require long-term structural support within the respiratory tract. Such conditions can lead to severe breathing complications and require immediate medical intervention to restore proper airflow. The growing preference among veterinarians and pet owners for minimally invasive treatment approaches has contributed to the increased use of airway stents. Additionally, advancements in stent material engineering, including self-expanding metal alloys and modern biodegradable materials, have improved device performance and expanded their clinical use within veterinary practices.

The dogs segment held 60.6% share in 2025. Market expansion within this segment is driven by the rising occurrence of medical conditions in canine populations that require stent-based treatment. Various structural complications affecting the respiratory, urinary, and vascular systems can require intervention through stent placement to restore normal physiological function. The high global population of companion dogs and increasing spending on veterinary healthcare further support the growth of this segment. Veterinarians are increasingly utilizing stent procedures as an effective treatment solution for dogs experiencing structural narrowing or obstructions within critical internal pathways.

North America Veterinary Stents Market accounted for 41.5% share in 2025. The region's leadership position is largely supported by its highly developed veterinary healthcare infrastructure and widespread availability of advanced treatment options for companion animals. Numerous specialized veterinary hospitals, referral centers, and advanced clinical facilities across North America are equipped to perform complex minimally invasive procedures, including stent implantation. In addition, strong consumer spending on pet healthcare and the availability of pet insurance programs contribute to greater affordability for advanced veterinary procedures. These factors collectively encourage the adoption of innovative veterinary treatment solutions and support the continued growth of the veterinary stents market across the region.

Key companies operating in the Global Veterinary Stents Market include Infiniti Medical, Dextronix, TaeWoong Medical, UltraVet Medical Devices, Create Medic, M.I. Tech, AbtVet (Stening Group), and EpiicVet. Companies competing in the Veterinary Stents Market are implementing several strategic initiatives to strengthen their market presence and expand global reach. Leading manufacturers are focusing heavily on research and development to introduce advanced stent designs with improved durability, flexibility, and biocompatibility. Many companies are also investing in the development of innovative materials and minimally invasive delivery systems to enhance treatment effectiveness and simplify clinical procedures for veterinarians. Strategic collaborations with veterinary hospitals, specialty clinics, and research institutions are helping companies improve product adoption and clinical validation. Additionally, market participants are expanding their distribution networks and strengthening regional partnerships to increase accessibility to veterinary stent technologies across emerging markets while maintaining strong competitiveness in established veterinary healthcare sectors.